Mersana Therapeutics
MRSN
MRSN
70 hedge funds and large institutions have $203M invested in Mersana Therapeutics in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 19 closing their positions.
Holders
70
Holders Change
-6
Holders Change %
-7.89%
% of All Funds
1.38%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
13
Increased
24
Reduced
22
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VMI
1
VHCP Management III
New York
|
$8.95M |
2 |
VMI
2
VHCP Management II
New York
|
$5.29M |
3 |
GTC
3
Ghost Tree Capital
New York
|
$4.58M |
4 |
4
Millennium Management
New York
|
$4.6M |
5 |
O
5
OrbiMed
New York
|
$11.9M |